EP0290442A4 - Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques. - Google Patents

Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.

Info

Publication number
EP0290442A4
EP0290442A4 EP19870900420 EP87900420A EP0290442A4 EP 0290442 A4 EP0290442 A4 EP 0290442A4 EP 19870900420 EP19870900420 EP 19870900420 EP 87900420 A EP87900420 A EP 87900420A EP 0290442 A4 EP0290442 A4 EP 0290442A4
Authority
EP
European Patent Office
Prior art keywords
mixtures
metal salts
active compounds
pharmacologically active
organic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870900420
Other languages
German (de)
English (en)
Other versions
EP0290442A1 (fr
Inventor
Russell T Jordan
Larry M Allen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of EP0290442A1 publication Critical patent/EP0290442A1/fr
Publication of EP0290442A4 publication Critical patent/EP0290442A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19870900420 1986-11-19 1986-11-19 Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques. Withdrawn EP0290442A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/002547 WO1988003805A1 (fr) 1986-11-19 1986-11-19 Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques

Publications (2)

Publication Number Publication Date
EP0290442A1 EP0290442A1 (fr) 1988-11-17
EP0290442A4 true EP0290442A4 (fr) 1990-07-03

Family

ID=22195725

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870900420 Withdrawn EP0290442A4 (fr) 1986-11-19 1986-11-19 Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.

Country Status (4)

Country Link
EP (1) EP0290442A4 (fr)
JP (1) JPH01501791A (fr)
AU (1) AU6866291A (fr)
WO (1) WO1988003805A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (fr) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions et procedes d'amelioration des caracteristiques d'aspect, croissance, ou cicatrisation cosmetique de tissus
JPH06507610A (ja) * 1991-05-16 1994-09-01 ウー，タイ−ウィン 酸化防止剤及び細胞保護剤として有用なプルプロガリンを含む医薬用組成物
US5248668A (en) * 1991-05-16 1993-09-28 Wintek Consulting Ltd. Use of purpurogallin and glycosides thereof in treating ischemia in mammals
FR2686512B1 (fr) * 1992-01-28 1995-06-30 Ir2M Compositions pharmaceutiques contenant comme principe actif des associations de vanadium et/ou de niobium avec des derives du pyrocatechol.
WO1995005156A1 (fr) * 1993-08-17 1995-02-23 Schering-Plough Healthcare Products, Inc. Compositions servant au traitement des cors, callosites et verrues
WO1995024894A2 (fr) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Utilisation d'inhibiteurs de la lipoxygenase en tant qu'agents therapeutiques et d'intervention anticancereux
GB9405046D0 (en) * 1994-03-15 1994-04-27 Unilever Plc Skin treatment composition
JPH0892157A (ja) * 1994-05-02 1996-04-09 F Hoffmann La Roche Ag プルプロガリン誘導体
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US7846919B2 (en) * 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
AU1140500A (en) * 1998-10-20 2000-05-08 Chen-Kung Chou Therapeutic compounds and methods
EP1200104A1 (fr) * 1999-07-09 2002-05-02 Cancer2 Inc. Compositions contenant du cadmium
US7033615B2 (en) 1999-07-09 2006-04-25 Cancer2 Inc. Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
JP4570184B2 (ja) * 1999-08-18 2010-10-27 卓二 田中 抗腫瘍剤
MXPA03000848A (es) * 2000-07-28 2004-12-13 Immupharm Aps Metodos para el tratamiento de sintomas del resfriado comun, rinitis alergica e infecciones relacionadas con el tracto respiratorio.
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
JP5362572B2 (ja) * 2006-10-02 2013-12-11 エリモス ファーマシューティカルズ エルエルシー テトラ−ｏ−置換ブタン架橋修飾ｎｄｇａ誘導体、それらの合成および薬学的使用
EP2315739B1 (fr) 2008-08-25 2014-11-12 DuPont Electronic Polymers L.P. Nouveaux propanoates et leurs procédés de préparation
US8609717B2 (en) 2010-08-18 2013-12-17 Samumed, Llc β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators
WO2014028657A1 (fr) 2012-08-15 2014-02-20 Mimedx Group, Inc Greffes de tissu placentaire renforcées et procédés de fabrication et d'utilisation de celles-ci
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US10206977B1 (en) 2013-01-18 2019-02-19 Mimedx Group, Inc. Isolated placental stem cell recruiting factors
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
BR112015020391B1 (pt) 2013-02-22 2022-07-26 Samumed, Llc Gama-dicetonas como ativadoras da via de sinalização de wnt/beta-catenina
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) * 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US9446142B2 (en) 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
KR101580716B1 (ko) * 2013-05-29 2015-12-30 숙명여자대학교산학협력단 라리아 니티다 추출물로부터 분리한 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는, 여성암과 갱년기 증상의 예방 및 치료용 약학적 조성물
US10449220B2 (en) 2013-08-30 2019-10-22 Mimedx Group, Inc. Micronized placental compositions comprising a chelator
US10052351B2 (en) 2014-01-17 2018-08-21 Mimedx Group, Inc. Method for inducing angiogenesis
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
EP3185918B1 (fr) 2014-08-28 2021-08-18 MiMedx Group, Inc. Greffe de tissu renforcée par collagène
CN114163411A (zh) * 2021-11-16 2022-03-11 宁波大学 一种对映体纯二氢杨梅素制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7760M (fr) * 1968-11-22 1970-03-16
US4084006A (en) * 1976-06-18 1978-04-11 Leach Byron E Method of using dialkylphenols an antiviral agents
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
EP0037800A2 (fr) * 1980-04-03 1981-10-14 Zyma SA Utilisation de dérivés O-substitués de (+)-cyanidanol-3 comme composés doués de propriétés immunomodulatrices
US4350707A (en) * 1976-02-05 1982-09-21 Research Corporation Inactivation of lipid containing viruses with butylated hydroxytoluene
WO1986006586A1 (fr) * 1985-05-03 1986-11-20 Chemex Pharmaceuticals, Inc. Excipients pharmaceutiques reducteurs du flux transdermique
WO1988001509A1 (fr) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Compositions pharmacologiquement actives de butanes catecholiqueset de zinc
WO1988003026A1 (fr) * 1986-10-28 1988-05-05 Chemex Pharmaceuticals, Inc. Compositions de butanes catecholiques avec du zinc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
DE2658307C2 (de) * 1976-12-22 1979-03-15 Klinge Pharma Gmbh & Co, 8000 Muenchen Di-O'-hydroxyphenyD-alkanverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7760M (fr) * 1968-11-22 1970-03-16
US4350707A (en) * 1976-02-05 1982-09-21 Research Corporation Inactivation of lipid containing viruses with butylated hydroxytoluene
US4084006A (en) * 1976-06-18 1978-04-11 Leach Byron E Method of using dialkylphenols an antiviral agents
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
EP0037800A2 (fr) * 1980-04-03 1981-10-14 Zyma SA Utilisation de dérivés O-substitués de (+)-cyanidanol-3 comme composés doués de propriétés immunomodulatrices
WO1986006586A1 (fr) * 1985-05-03 1986-11-20 Chemex Pharmaceuticals, Inc. Excipients pharmaceutiques reducteurs du flux transdermique
WO1988001509A1 (fr) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Compositions pharmacologiquement actives de butanes catecholiqueset de zinc
WO1988003026A1 (fr) * 1986-10-28 1988-05-05 Chemex Pharmaceuticals, Inc. Compositions de butanes catecholiques avec du zinc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8803805A1 *

Also Published As

Publication number Publication date
EP0290442A1 (fr) 1988-11-17
JPH01501791A (ja) 1989-06-22
WO1988003805A1 (fr) 1988-06-02
AU6866291A (en) 1991-03-14

Similar Documents

Publication Publication Date Title
EP0290442A4 (fr) Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
OA09148A (en) Pharmacologically active CNS compounds.
NL192201B (nl) Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en prepa- raten die deze verbindingen bevatten.
FI904444A0 (fi) Aktiva limkompositioner.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NO852561L (no) Farmakologisk aktive, substituerte benzamider.
NZ221513A (en) Triazolylmethyl- and imidazolylmethyl- 2,5-dihydrofuran derivatives and fungicidal compositions
NZ219606A (en) 1,1-disubstituted-cyclopropane derivatives and fungicidal compositions
IT8820550A0 (it) Benzammidi sostituite farmacologicamente attive.
DE3585873D1 (de) Vinylbenzyl-2,2,6,6-tetramethylpiperidine.
ZA782781B (en) Pharmacologically active substituted 1,2,4-triazines
IT8920405A0 (it) Aminoimidazopiridine farmacologicamente attive.
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
IT8521235A0 (it) Composti farmacologicamente attivi.
GB8622090D0 (en) Pharmacologically active compounds
KR890700028A (ko) 약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
ATE85185T1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
EP0634394A3 (fr) Composé organique fluoré.
NZ219949A (en) Cyanoacetamido derivatives having fungicidal activity, fungicidal compositions and intermediate compounds
EP0419157A3 (en) Pharmacologically active compound., preparation and use
AU6779487A (en) Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
FI865244A (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
EP0603160A3 (fr) Compositions pour assemblage "in-situ" de composés adtifs.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880718

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CHEMEX PHARMACEUTICALS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CHEMEX PHARMACEUTICALS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CHEMEX PHARMACEUTICALS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19900703

17Q First examination report despatched

Effective date: 19910701

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920114